The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Global Health’s (GLH) shares have soared over 52 per cent on the back of a partnership with Asthma Australia
  • Asthma Australia is an organisation aiming to half asthma hospitalisations by 2030
  • Nearly three million Australians live with asthma – costing the health care industry $28 billion each year
  • The companies have partnered to improve outcomes for asthma sufferers by using Global Health’s Lifecard platform
  • Lifecard connects consumers with care teams and health care professionals which allows consumers to avoid retelling their health history
  • Lifecard is integrated with Global Health’s secure messaging platform, ReferralNet and will soon be integrated with asthma-related data
  • Global Health’s shares have soared 52.2 per cent to trade for 35 cents

Global Health’s (GLH) shares have soared over 52 per cent on the back of a partnership with Asthma Australia for its Lifecard consumer health platform.

Currently, nearly three million Australians live with asthma which costs the health care industry $28 billion each year. Almost half of these asthma sufferers can’t control their condition with triggers such as air pollution and changes in weather.

Asthma Australia aims to half asthma hospitalisations by 2030.

The Lifecard platform connects consumers with their care teams – giving them the opportunity to better comply with prescribed care plans.

Lifecard is integrated with Global Health’s secure messaging platform, ReferralNet, which allows subscribers to receive health and medical information directly to their Lifecard personal health record.

GLH is also planning to integrate asthma-related data from wearables to the Lifecard phone app.

“We often hear that people with asthma get rather exhausted retelling their health history, which can be complex and traumatic, and that doctors appreciate the opportunity to assess a health record,” Asthma Australia CEO Michele Goldman said.

“We see this partnership as a great opportunity for people with asthma to embrace a health tool, and another step toward individualised, person-centred health care,” Michele added.

The company has begun to integrate Lifecard with wearable and remote monitoring devices. The additional data will hopefully facilitate a real-time view of a consumer’s health within their Lifecard record. This will enable health care workers to make more informed decisions regarding their health.

“We are looking forward to the year ahead and what we can achieve together with Asthma Australia,” Global Health Managing Director Mathew Cherian said.

Global Health’s shares have soared 52.2 per cent to trade for 35 cents at 3:08 pm AEDT.

GLH by the numbers
More From The Market Online
AI image of a scan on kidneys

Dimerix links up with US NEPTUNE network to boost recruitment for FSGS study

Dimerix Ltd is set to partner with a key research network at the University of Michigan…
Blind person with guide dog

Biotech stock PYC doses first patient in rare blindness-causing disease trial

PYC has dosed its first patient in a clinical trial seeking to ameliorate symptoms of Autosomal…
Image of a brain

Emyria, UWA seek commercialisation of compounds to treat PTSD and Parkinson’s

Emyria and the University of Western Australia have formed a partnership to secure global rights to…
Image of a baby's brain

FDA awards Argenica two key designations for drug candidate targeting infant brain injury

Argenica Therapeutics Ltd has received two key designations from the US Food and Drug Administration for…